Literature DB >> 1372586

CFTR illegitimate transcription in lymphoid cells: quantification and applications to the investigation of pathological transcripts.

N Fonknechten1, J Chelly, J Lepercq, A Kahn, J C Kaplan, A Kitzis, J C Chomel.   

Abstract

Since the isolation of the cystic fibrosis transmembrane conductance regulator gene (CFTR) and the characterization of the main mutation (delta F508) in 1989, a large number of rare mutations has been found. Full screening of the CFTR gene is difficult because it is split into 27 exons covering 250 kb of genomic DNA. This gene is essentially expressed in the lung and intestinal tract, neither of which are easily accessible for routine investigations. The recent description of a faint transcription of highly tissue-specific genes in any cell, a phenomenon known as illegitimate transcription, would facilitate the research of mutations and the characterization of truncated m-RNA caused by splicing mutations. Using the polymerase chain reaction on cDNA (cDNA-PCR), we detected transcripts of the CFTR gene in lymphocytes and lymphoblast cells at a very low level (about 300 times less than in lung or intestine). This strategy allowed us to obtain a sufficient amount of cDNA-PCR product compatible with further molecular analyses. We have, therefore, analyzed a cDNA fragment overlapping exons 10 and 11 by polyacrylamide gel electrophoresis and direct sequencing, and detected the delta F508 mutation at this level. Our protocol can be generalized to the investigation of the total 4.5-kb CFTR coding sequence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372586     DOI: 10.1007/bf00219336

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  23 in total

1.  Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome.

Authors:  B Knebelmann; L Boussin; D Guerrier; L Legeai; A Kahn; N Josso; J Y Picard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  Quantitative estimation of minor mRNAs by cDNA-polymerase chain reaction. Application to dystrophin mRNA in cultured myogenic and brain cells.

Authors:  J Chelly; D Montarras; C Pinset; Y Berwald-Netter; J C Kaplan; A Kahn
Journal:  Eur J Biochem       Date:  1990-02-14

3.  Worldwide survey of the delta F508 mutation--report from the cystic fibrosis genetic analysis consortium.

Authors: 
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

4.  Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity.

Authors:  G Sarkar; S S Sommer
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

5.  Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis.

Authors:  M Vidaud; P Fanen; J Martin; N Ghanem; S Nicolas; M Goossens
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  A frame-shift mutation in the cystic fibrosis gene.

Authors:  M B White; J Amos; J M Hsu; B Gerrard; P Finn; M Dean
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

8.  A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein.

Authors:  G R Cutting; L M Kasch; B J Rosenstein; J Zielenski; L C Tsui; S E Antonarakis; H H Kazazian
Journal:  Nature       Date:  1990-07-26       Impact factor: 49.962

9.  Transcription of the dystrophin gene in human muscle and non-muscle tissue.

Authors:  J Chelly; J C Kaplan; P Maire; S Gautron; A Kahn
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

10.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

View more
  5 in total

1.  Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the human brain.

Authors:  Yong Guo; Min Su; Michael A McNutt; Jiang Gu
Journal:  J Histochem Cytochem       Date:  2009-08-03       Impact factor: 2.479

2.  Molecular cloning and heterologous expression of an alternatively spliced human Mu class glutathione S-transferase transcript.

Authors:  V L Ross; P G Board
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

3.  Unexpected inactivation of acceptor consensus splice sequence by a -3 C to T transition in intron 2 of the CFTR gene.

Authors:  T Bienvenu; D Hubert; N Fonknechten; D Dusser; J C Kaplan; C Beldjord
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

4.  A novel donor splice site in intron 11 of the CFTR gene, created by mutation 1811+1.6kbA-->G, produces a new exon: high frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype.

Authors:  M Chillón; T Dörk; T Casals; J Giménez; N Fonknechten; K Will; D Ramos; V Nunes; X Estivill
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

5.  Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the spinal cord.

Authors:  Yong Guo; Min Su; Meng Su; Michael A McNutt; Jiang Gu
Journal:  J Neurosci Res       Date:  2009-12       Impact factor: 4.164

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.